A key step in the Fanconi anemia (FA) tumor suppressor pathway is the site-specific monoubiquitination of the FANCD2 protein. Genetic studies indicate that this crucial modification requires eight known FA gene products and the E2-conjugating enzyme Ube2t. Here, we minimally reconstitute this monoubiquitination reaction with Ube2t and the FANCL protein, revealing that monoubiquitination is stimulated by a conserved RWD-like domain in FANCL. Furthermore, addition of the FANCI protein enhances monoubiquitination and also restricts it to the in vivo substrate lysine residue on FANCD2. This work therefore establishes a system that provides mechanistic insight into the functions of FANCL and FANCI in the catalysis of FANCD2 monoubiquitination.
INTRODUCTION
The Fanconi anemia tumor suppressor pathway plays a crucial role in the maintenance of genomic integrity in eukaryotic cells. The phenotypic consequences of inactivation of this pathway are strikingly displayed in the human genetic illness Fanconi anemia (FA). In fact, inactivation of any one of 12 autosomal genes or one X chromosome-linked gene results in developmental abnormalities, bone marrow failure, and cancer predisposition. Considerable genetic and biochemical evidence indicate that most of the FA proteins function in a distinct DNA damage response pathway (reviewed in Joenje and Patel, 2001; Patel and Joenje, 2007; Wang, 2007) . More specifically, most of the FA proteins bind each other to form a large nuclear complex (FA core complex) that responds to DNA damage that impedes DNA replication. This nuclear complex responds to DNA damage by stimulating the monoubiquitination of two downstream FA proteins: FANCD2 and FANCI (Garcia-Higuera et al., 2001; Sims et al., 2007; Smogorzewska et al., 2007) . The monoubiquitination of at least FANCD2 is conserved in evolution and is essential for the pathway to function, and most clinical cases of FA are due to inactivation of this step. These reasons underscore the importance in understanding the mechanism of FANCD2 monoubiquitination.
Ubiquitin transfer reactions usually require a relay of enzymes, starting with an E1 ubiquitin-activating enzyme, a multitude of E2-conjugating enzymes, and eventually, a vast number of E3 ubiquitin-ligating enzymes. The choice of monoubiquitin rather than polyubiquitin chain formation and substrate specificity depends largely on the interaction between E2 and E3 enzymes (reviewed in Pickart, 2001) . Current genetic work indicates that the relevant E2 enzyme for FANCD2 monoubiquitination is Ube2t (Alpi et al., 2007; Machida et al., 2006) , and the E3 enzyme most likely resides within the FA core complex (Meetei et al., 2003) . Although genetic studies in vertebrates show that at least eight FA proteins are essential for FANCD2 monoubiquitination, it seems very likely that the RING-finger-containing FANCL subunit is the crucial E3 ligase subunit and that it can physically interact with Ube2t (Alpi et al., 2007; Machida et al., 2006; Meetei et al., 2003) . Despite the progress in identifying the putative E2 and E3 enzymes responsible for this response, direct biochemical evidence to support this notion is currently lacking. In addition, it is not known how Ube2t and the FANCL subunit catalyze site-specific FANCD2 monoubiquitination as opposed to polyubiquitination. Finally, it remains a mystery how DNA damage stimulates this ubiquitin relay in cells.
To directly address these questions, we describe an in vitro system that reconstitutes FANCD2 monoubiquitination. We find that at least two E2 enzymes (Ube2t and Ube2w) are capable of interacting with FANCL and of stimulating FANCD2 monoubiquitination. In addition to interacting with the requisite E2, FANCL possesses a highly conserved RWD-like domain that stimulates ubiquitin-charged Ube2t to monoubiquitinate FANCD2. Finally, the addition of FANCI to our in vitro system both stimulates FANCD2 monoubiquitination and also restricts it to the correct in vivo lysine.
RESULTS

Ube2t and Ube2w Can Stimulate FANCD2 Monoubiquitination In Vitro
As a first step to reconstitute FANCD2 monoubiquitination, we needed to identify the E2 enzyme(s) that feeds this reaction. A natural starting point is to search for binding partners of FANCL, which is the only known component of the FA core complex that possesses a RING finger domain that is found in the subfamily of E3 ubiquitin RING ligases (Meetei et al., 2003) . Full-length human FANCL was used as bait to screen a human testes cDNA library using the yeast two-hybrid interaction trap. Two E2 enzymes were identified, Ube2t and Ube2w ( Figure 1A ). Ube2t has recently been shown to be the actual E2 enzyme for the FANCD2 monoubiquitination in vivo. This is based on siRNA knockdown studies in human cells (Machida et al., 2006) and subsequently by gene deletion in DT40 cells (Alpi et al., 2007) . In both instances Ube2t seems to be essential for FANCD2 monoubiquitination. Ube2w is known to interact with the BRCA1/BARD1 RING domain and to catalyze BRCA1 monoubiquitination (Christensen et al., 2007) . However, Ube2w has yet to be genetically characterized, and so far siRNA knockdown experiments in human cells have not been successful (data not shown). In an extension to the yeast two-hybrid interaction studies, we next tested to see whether the two E2 enzymes directly interact with full-length FANCL and its two isolated domains, WD40 (N-terminal WD40 repeat-containing region) and RING (C-terminal RING finger domain). To achieve this, we had to express and purify full-length FANCL as well as the isolated N-and C-terminal domains. Initially we tried to express human FANCL, but we found that this protein was insoluble in all suitable buffer conditions, although this was not the case for chicken FANCL (data not shown). These polypeptides were expressed in insect cells as N-terminal GST fusion proteins, and purification was carried out by GST affinity chromatography followed by elution with protease cleavage from the GST-tag ( Figure 1B domains were incubated and precipitated with Glutathione beads, and the E2/ FANCL complex (E) was eluted by protease treatment, leaving the GST-tag on beads. These studies ( Figure 1C and 1D, lane 4) clearly show that Ube2t and Ube2w directly interact with full-length FANCL. However, neither the isolated RING finger domain (RING) nor the N-terminal region (WD40) is sufficient for this interaction, indicating that multiple interaction sites must mediate the binding of Ube2t or Ube2w to FANCL ( Figure 1C , lanes 8 and 12, and Figure 1D , lanes 8 and 12).
In order to reconstitute FANCD2 monoubiquitination, we set out to express and purify chicken FANCD2. This protein was engineered to express as a tandem affinity purification tag (TAP-tag) fused to the C terminus (see Experimental Procedures for details). Following TAP affinity purification and a subsequent gel filtration chromatography step, we obtained highly purified FANCD2 protein (Figure 2A) . Briefly, the in vitro ubiquitination assay consists of radiolabeled 125 I-ubiquitin, ATP, E1/E2/E3 enzymes, and the substrate. The products of the reaction are then resolved by either nonreducing (to analyze thiolester-linked ubiquitin products) or reducing (to reveal isopeptide-linked ubiquitin products) SDS-PAGE. Autoradiography visualizes all these possible ubiquitin-conjugated products. By leaving out various components we can determine the identity of the ubiquitinated products (Vandenberg et al., 2003) . E2 enzymes are known to possess active cysteine sites that form a transient thiolester bond with ubiquitin. This is an essential prerequisite for the subsequent ubiquitin transfer reaction (reviewed in Pickart, 2001) . In order to determine whether both Ube2t and Ube2w carry such an active site, we incubated GST-fusion proteins of these enzymes with E1 enzyme and 125 I-ubiquitin. The ubiquitin-conjugated products were resolved by nonreducing (lanes 1-3) or reducing SDS-PAGE (lanes 4-6) (see Figures S1A and 1B available online). It is clear that both Ube2t ( Figure S1A ) and Ube2w ( Figure S1B ) are conjugated to a single ubiquitin molecule, which is sensitive to reducing conditions (compare lane 1 with lane 4). However, unlike Ube2w, a proportion of Ube2t remains attached to ubiquitin, indicating that this protein is capable of autoubiquitination ( Figure S1A ). We note here that the single discrete band might represent a mixture of reducible as well as nonreducible ubiquitinated Ube2t species. We extended these experiments to determine whether Ube2t or Ube2w with FANCL can conjugate a single ubiquitin onto FANCD2. Indeed, Ube2w ( Figure 2B ) and to a lesser extent Ube2t ( Figure 2C) which allows the protein to be captured by calmodulin affinity chromatography (Gould et al., 2004) . The data in Figure 2D show that, upon completion of the reaction followed by a precipitation on calmodulin-binding beads, a radiolabeled species with the molecular weight of 170 kDa was detected. The relevant controls run in parallel with this reaction led us to conclude that the 170 kDa species represents monoubiquitinated FANCD2.
Ube2t Autoubiquitination Does Not Regulate FANCD2 Monoubiquitination
We have shown here that Ube2t is autoubiquitinated ( Figure 2C ). This has also been observed in vivo (Machida et al., 2006) . Moreover, it has already been established that Ube2t is monoubiquitinated on lysine 91, and that this modification is believed to inhibit the E2 enzyme with respect to FANCL ubiquitination (Machida et al., 2006) . However, the effect of the Ube2t autoubiquitination on FANCD2 monoubiquitination has not yet been addressed. Initially we reconstituted this autoubiquitination reaction in vitro and observed that monoubiquitinated Ube2t resolves as two distinct species by SDS-PAGE. Mass spectrometry analysis of this protein species confirmed that K91 and K182 (redundant to K191) are the main sites for this modification in vitro ( Figure S2A ). These sites were either mutated (K91R) or deleted (K182/K191 by removal of the last 18 amino acids). In addition we mutated the active site cysteine as a control (C86A). The relevant recombinant wild-type and the various Ube2t mutant proteins were expressed and purified ( Figure S2B ), and then assessed in the in vitro system. In the ubiquitination reaction outlined in Figure 3A , autoubiquitination is dependent on catalytically active Ube2t ( Figure 3A , lane 4). Neither full-length Ube2t with a K91R point mutation nor the fragment with the C-terminal deletion (Ube2tDC) could abolish autoubiquitination ( Figure 3A , lane 6 and lane 8, respectively), thereby indicating that both sites are ubiquitinated. To confirm this further, we combined both mutations and now found that autoubiquitination was greatly reduced ( Figure 3A , lane 10).
Having established the predominant autoubiquitination sites on Ube2t, we wanted to see whether Ube2t that cannot be autoubiquitinated is constitutively active. To test this we preincubated E1, Ube2t (wild-type or relevant mutant proteins), and FANCL with 125 I-ubiquitin in order to ensure maximal Ube2t autoubiquitination. FANCD2 was then added to this reaction and incubated for a further 30 min, and the reaction products were resolved by SDS-PAGE ( Figure 3B ). The autoradiograms in Figure 3B show that the autoubiquitination-defective Ube2t is indistinguishable from wild-type Ube2t in the monoubiquitination of FANCD2 and FANCL (compare lanes 2, 6, 8, and 10). In order to extend on these in vitro results, we asked if ubiquitin-defective point mutants of Ube2t could complement a DT40 UBE2T-deficient cell line. Indeed, the data clearly show that human Ube2t (hUBE2T) and the autoubiquitination-dead mutant [hUBE2TDC(K91R)] are both capable of functionally (crosslinker sensitivity) ( Figure 3C ) and biochemically ( Figures 3D and 3E ) rescuing the ube2t À/À cell line.
We therefore conclude that Ube2t is autoubiquitinated at two distinct sites, yet this modification has no detectable functional impact on the monoubiquitination reactions in vitro and in vivo.
A Conserved RWD-like Domain in FANCL Stimulates Monoubiquitination by Ube2t
As demonstrated in Figure 1 , only the full-length FANCL is capable of interacting with Ube2t ( Figure 1C ) and Ube2w (E) Indicated cell lines were treated with 500 ng/ml MMC, and extracts were prepared after certain time points (0, 1, 2, 4 hr) and subjected to FANCD2 immunoblot analysis. Autoubiquitination mutant Ube2t does not effect the kinetics of FANCD2 monoubiquitination. D2-Ub, monoubiquitinated FANCD2; D2, unmodified FANCD2. Asterisk indicates nonreduced, ubiquitinated E1 enzyme.
( Figure 1D ). This finding prompted us to carry out a careful computational analysis of the FANCL sequence (see Experimental Procedures). In particular, we concentrated on the N-terminal region, which appears to contain three WD40-like repeats (Meetei et al., 2003) . Previous work has shown that this region may anchor the FANCL protein within the FA core complex . However, a minimum of four WD40 repeats are normally required to form a beta-propeller-like structure (Kraft et al., 2005) . In addition to confirming the three WD40 repeats, we also noticed that the WD40 repeats are organized into a predicted RWD-like domain (named after the three major classes of RWDcontaining proteins-RING finger proteins, WD-repeat proteins, and yeast DEAD-like helicases) ( Figure 4A ) (Doerks et al., 2002; Nameki et al., 2004) . This recently identified domain structurally resembles an E2-like fold and functionally has been shown to enhance sumoylation by the Ubc9 enzyme (Carbia-Nagashima et al., 2007) . Molecular modeling of the FANCL sequence onto the known RWD domain structure allowed us to identify critical residues, in particular a conserved tyrosine and prolines in the sequence YPxxxP. This highly conserved amino acid sequence forms a triple-turn motif ( Figure 4A ), and mutations of these residues reduce the ability of this domain in stimulating Ubc9 activity (Carbia-Nagashima et al., 2007) . Our next step was to functionally test the importance of the putative RWD-like domain in FANCL. In the first instance we looked to see if FANCL enhanced the charging of Ube2t with thiolester-linked ubiquitin. Increasing the concentration of FANCL incubated with a fixed concentration of Ube2t results in enhanced reducible conjugation of 125 I-ubiquitin onto Ube2t ( Figure 4B, top) . Indeed, it is interesting to note that this enhancement of thiolester-linked 125 I-ubiquitin does not induce autoubiquitination of Ube2t, as shown under reducing conditions ( Figure 4B, bottom) . We then expressed and purified a FANCL protein carrying mutations of both Y156 and P157 to alanines. These mutations are predicted to disrupt the crucial triple-turn motif. The data in Figure 4C shows that titrating RWD-like mutated FANCL (FANCL-RWDmut) does not induce Ube2t charging. Next we questioned if this was of consequence for FANCD2 monoubiquitination in vitro and in vivo. Equal amounts of FANCL and FANCL variants (including RWD-like mutated FANCL, isolated RING, and RWD-like [originally named WD40 in Figure 1 ] domains) were tested in a complete ubiquitination reaction with FANCD2. Different levels of FANCD2 monoubiquitination are shown in the autoradiogram ( Figure 4D, top) . In order to compare these differences, we carried out quantitative analysis of three independent experiments ( Figure 4D, bottom) . Data are calculated as a ratio of induced FANCD2 monoubiquitination relative to a reaction without FANCL. The relative inductions by the RING (1.0 ± 0.33) and the RWD-like (1.2 ± 0.26) domains clearly demonstrate a deficiency in promoting FANCD2 monoubiquitination. Moreover, the comparison of induced FANCD2 monoubiquitination by RWD-like mutated FANCL (1.8 ± 0.36) with wild-type FANCL (2.5 ± 0.42) reveals a $25% defect that indicates the importance of a functional RWD-like domain in FANCL.
Finally, we expressed the RWD-like mutant FANCL (TAP-LRWDmut) in DT40 FANCL deletion cell lines (fancl À/À ) to test the in vivo impact of this mutation. We predict that this mutant should be able to interact with Ube2t and also to assemble into the FA core complex. Therefore, it should still be able to monoubiquitinate FANCD2 albeit inefficiently. We first confirmed that TAP-L-RWDmut is indeed assembled in a high-molecular-weight complex using size exclusion chromatography. The chromatographic properties of TAP-FANCL-RWDmut (TAP-L-RWDmut) were comparable with wild-type TAP-FANCL (TAP-L), which elutes in two major fractions (1.5 MDa and 0.3-0.5 MDa, respectively) ( Figure 4F ) (Alpi et al., 2007; Machida et al., 2006) . MMCinduced FANCD2 monoubiquitination was then assessed by FANCD2 immunoblot analysis combined with quantification of the ratios between small FANCD2 (D2) and large FANCD2 (D2-Ub) ( Figure 4E, top) . This reveals that the RWD-like mutant FANCL-complemented cell line has a defect in DNA damage (MMC)-induced FANCD2 monoubiquitination compared to the wild-type FANCL-complemented cell line (D2-Ub/D2 ratio of 0.58 ± 0.03 and 1.18 ± 0.01, respectively) ( Figure 4E , bottom).
To further compare defects of the mutated RWD-like domain with mutations in the RING domain (that disturb binding to Ube2t), we also included in this analysis fancl À/À cell lines expressing mutant forms of FANCL. In these constructs the conserved cysteines in the RING domain have been mutated (TAP-L-C305A and TAP-L-C357A) (Alpi et al., 2007) . In contrast to FANCL-RWDmut, these RING domain mutants completely abolish endogenous and MMC-induced monoubiquitination of FANCD2 ( Figure 4E ). The partial defect of FANCL-RWDmut in FANCD2 monoubiquitination correlates with an inability for this mutant to fully complement the crosslinker hypersensitivity in the fancl À/À cell line ( Figure 4G ). In summary, we have discovered an RWD-like domain within the N terminus of FANCL that enhances the efficiency of FANCD2 monoubiquitination by stimulating Ube2t activity.
FANCI Stimulates and Site-Restricts FANCD2 Monoubiquitination
In vivo FANCD2 monoubiquitination is restricted to a single specific lysine (K561 in humans and K563 in chickens) (GarciaHiguera et al., 2001; Grompe and van de Vrugt, 2007; Matsushita et al., 2005) . To see if we could reconstitute site specificity in vitro, we compared titrations of wild-type FANCD2 with FANCD2 containing a K563R amino acid substitution [FANCD2(K563R)] in complete ubiquitination reactions including Ube2t and FANCL. Figure 5A clearly shows that mutant FANCD2(K563R) can be monoubiquitinated in a concentration-dependent manner, although with lower efficiency than wild-type protein ( Figure 5B ). These results indicate that Ube2t and FANCL are not sufficient to restrict the ubiquitin transfer to the correct lysine K563. To address the site specificity for FANCD2 monoubiquitination, we asked if the known proteins that bind directly to FANCD2 can restrict monoubiquitination to the correct lysine. FANCD2 forms an interaction with the FA core complex protein FANCE (Pace et al., 2002) and with the FANCI protein (I/D2 complex) (Sims et al., 2007; Smogorzewska et al., 2007) . First we tested the effect of FANCE. The addition of purified recombinant FANCE to our standard ubiquitination assay had no effect on FANCD2 monoubiquitination (data not shown). This could be because the added FANCE may be unable to bind FANCD2. Therefore we reconstituted and purified recombinant FANCD2/FANCE and FANCD2 (K563R)/FANCE complexes. Both the wild-type and mutant FANCD2 form a stable complex with FANCE of comparable stoichiometry as determined by gel filtration chromatography profiles (data not shown) and SDS-PAGE ( Figure 5C ). Equimolar quantities of both complexes were then tested as substrates in the ubiquitination reaction. FANCD2 monoubiquitination occurred in both instances ( Figures 5D and 5E ), indicating to us that FANCE does not site-restrict this modification. We then tested whether FANCI plays any direct role in the monoubiquitination of FANCD2. A recombinant GST-tagged human FANCI fusion protein ( Figure 6A ) was purified and tested for its ability to stimulate FANCD2 monoubiquitination. Since we are using human FANCI in our assay, we first confirmed that this protein is indeed able to interact with chicken FANCD2. To probe such an interaction we carried out a mammalian two-hybrid interaction assay. The data in Figure 6B clearly show that the two proteins can interact. Next, we titrated increasing concentrations (0, 20, and 100 nM) of GST-FANCI to the ubiquitination reaction while keeping a constant FANCD2 concentration (100 nM). The data shown in Figure 6C demonstrate that GST-FANCI stimulates robust FANCD2 monoubiquitination (lane 1 to 3). This stimulation is specific to FANCI because the GST polypeptide ( Figure 6C , lane 4) alone has no effect. To extend this line of investigation, we then tested if the stimulation of FANCD2 monoubiquitination is specific to lysine K563. A fixed concentration of 90 nM FANCD2 or FANCD2(K563R) was treated with increasing concentrations of GST-FANCI in the assay (Figure 6D) . Quantities of FANCD2 and GST-FANCI were confirmed by immunoblot analysis. These data demonstrate that GST-FANCI stimulates monoubiquitination of wild-type FANCD2 but not the mutant FANCD2(K563R). In summary, we show that FANCI but not FANCE stimulates FANCD2 monoubiquitination. Since this stimulatory effect is seen only with the wild-type and not the mutant FANCD2(K563R), we conclude that FANCI is required for restriction of the monoubiquitination to the specific in vivo monoubiquitinated lysine residue on FANCD2.
DISCUSSION
This paper describes the establishment of an in vitro system that reconstitutes FANCD2 monoubiquitination. This system has allowed us to conclude that (1) Ube2t is responsible for monorather than polyubiquitin transfer, (2) FANCL recruits and stimulates the activity of Ube2t through its RING finger and an RWDlike domain, respectively, and (3) FANCI enhances and restricts the modification to the correct lysine residue on FANCD2. Cumulatively, these conclusions provide fresh insight into the molecular mechanism of this fundamental and pivotal step in the FA pathway (summarized in the model shown in Figure 6E ).
In both our in vitro and in vivo systems, we observe strict monoubiquitination of FANCD2. However, this is a property that seems specific to both Ube2t and Ube2w, since incubation of FANCD2 in the presence of UbcH5a leads to polyubiquitination. Therefore, it would appear that it is Ube2t that determines monoubiquitination. A recent study has shown that BRCA1 can interact with many E2 enzymes, some which result in polyubiquitination and others that lead only to monoubiquitination (Christensen et al., 2007) . This difference was attributed to the fact that certain E2 enzymes like Ube2w or indeed Ube2t might lack a ubiquitin-binding domain that would reprime the active site upon transfer of ubiquitin. A consequence of E2 enzymes that cannot bind ubiquitin might explain their weak conjugation activity, in particular a lack of processive activity crucial for polyubiquitination. We have found that FANCL has an additional function other than recruiting Ube2t to the specific substrate. It contains a highly conserved RWD-like domain. This domain stimulates the activity of Ube2t. It is not known how precisely this domain works, and to the best of our knowledge this is the first example of its role in ubiquitin transactions. One likely mechanism would be that the RWD-like domain stabilizes the ubiquitin-charged Ube2t (Ubiquitin-C86 thiolester), favoring a conformation for the subsequent ubiquitin transfer onto FANCD2 ( Figure 6E, [1] ). Therefore, its role in FANCD2 monoubiquitination might be to enhance the weak activity of Ube2t ( Figure 6E, [2] ). Despite the additional function of FANCL in enhancing Ube2t activity, the monoubiquitination reaction that we report here is weak, and only a small amount of FANCD2 is modified. This, however, is not the case in cells where rapid monoubiquitination of up to 50% of FANCD2 can be achieved within a few hours (Garcia-Higuera et al., 2001 ). An important focus for present and future work will be to identify the accessory factors that make the in vivo monoubiquitination of FANCD2 so efficient. ). Standard errors of the means are given from three independent experiments. Asterisk indicates nonreduced, ubiquitinated E1 enzyme.
We recognize the fact that, in vertebrate cells, monoubiquitination of FANCD2 does not occur (or indeed is seriously limited) if the FA core complex is compromised. However, it is clear from the work presented here that Ube2t, FANCL, and FANCI are sufficient to recapitulate many aspects of the in vivo situation. How might the other FA proteins in this complex contribute to monoubiquitination? One important factor to consider is that the FA complex resides in the nucleus, responding to DNA damage by translocating to chromatin (Mi and Kupfer, 2005; Oestergaard et al., 2007) . Moreover, the FANCL subunit is unstable unless it is embedded in this complex (Meetei et al., 2003) . Additionally, the FANCE subunit binds FANCD2 directly and is the likely subunit that recruits FANCD2 to the complex (Pace et al., 2002) . These factors may explain why the other FA core complex proteins and/or indeed a stable nuclear complex may be essential for the cell biology of FANCD2 monoubiquitination. Certain metazoans such as flies, worms, and the social amoeba seem to lack the full complement of FA core complex genes (Collis et al., 2006; Marek and Bale, 2006; Patel and Joenje, 2007) . In these organisms there appears to be a simplified FANCD2 monoubiquitination pathway where E1, Ube2t, FANCL, and FANCI may be sufficient for FANCD2 monoubiquitination. Lower organisms may therefore possess a simplified FA monoubiquitination pathway, which consist of just the minimal catalytic components that we have defined here (Ube2t, FANCL, and FANCI).
We do not know how FANCI both stimulates and restricts FANCD2 monoubiquitination. This protein binds to FANCD2, but the interaction does not seem to be a very strong one (Ishiai et al., 2008; Smogorzewska et al., 2007) . In addition, it is unclear how much FANCD2 is in a complex with FANCI ( Figure 6E, [3] ). One plausible explanation is that binding of FANCI to FANCD2 alters the conformation of FANCD2, allowing the protein to be monoubiquitinated exclusively on the correct lysine residue ( Figure 6E, [4] ). The functional role of FANCI monoubiquitination was undefined in our study. The fact that FANCI is not modified in our assay suggests that this is not strictly required for FANCD2 monoubiquitination. It is noteworthy that a FANCI point mutant abolishing its monoubiquitination still largely complements the FANCI cellular defect (Ishiai et al., 2008; Smogorzewska et al., 2007) . Moreover, the molecular requirements for FANCI monoubiquitination are not completely known. We speculate that the lack of FANCI monoubiquitination in our system may be because of the lack of the relevant E2 or E3 enzymes. Finally, we do not have an explanation for how DNA damage induces FANCD2 monoubiquitination in vivo. This emphasizes the fact that the in vitro assay does not support robust monoubiquitination of FANCD2. It is possible that phosphorylation of the FA complex subunits or of FANCI can provide the potential trigger for FANCD2 monoubiquitination (Mi et al., 2004; Smogorzewska et al., 2007) . Indeed, some of these proteins are substrates of the ATR DNA damage checkpoint kinase, which is known to be important for stimulating FANCD2 monoubiquitination (Andreassen et al., 2004) . A recent study addressed the relevance of posttranslational modifications on FANCI. They demonstrated that hyperphosphorylated FANCI stimulates DNA-damage-induced monoubiquitination of FANCD2 in vivo (Ishiai et al., 2008) . How this modification augments DNA-damage-induced FANCD2 monoubiquitination is not known. However, our in vitro system now provides an ideal platform to determine how such factors may enhance and regulate the FANCD2 monoubiquitination reaction.
EXPERIMENTAL PROCEDURES
DT40 Cell Culture DT40 cell transfections, FANCD2 immunoblot analyses, cisplatin sensitivity assays, and gel filtration chromatography were done as described previously (Mosedale et al., 2005; Niedzwiedz et al., 2004) . 
Protein Expression and Purification
Experimental details for protein expressions and purifications are provided in the Supplemental Data.
Yeast Two-Hybrid Interaction Chicken FANCL cDNA was amplified as a SalI/NotI fragment with adapted oligomers. PCR product was then cloned into pDBLeu containing a GAL4DBD cDNA. A human testes library was screened with pDBLeu (GgFANCL) as bait using the ProQuest Two-Hybrid System (GIBCO) following the manufacturer's instructions. Two candidates, UBE2T and UBE2W, were isolated as multiple hits. Full-length cDNAs of these (see above) were amplified as SalI/NotIadapted PCR fragments and cloned into the GAL4DBD-encoding vector pDBLeu. The EcoRI/NotI fragment of UBE2T cDNA and the SalI/NotI fragment of UBE2W cDNA were each cloned into a pPC86 vector containing a GAL4AD cDNA. Ube2t and Ube2w interactions with FANCL were retested in reversed orientations (Figure 2A ).
Mammalian Two-Hybrid Interaction
Full-length human FANCI and chicken FANCD2 cDNA (see above) were amplified as SalI/NotI-adapted PCR fragments and cloned into the GAL4 DNA-binding domain encoding vector pM and into the VP16 activation domain encoding vector pVP16. Interaction assays were done as described previously (Medhurst et al., 2006) .
Ubiquitination Assay
Standard 20 ml reactions contained 10 nM human recombinant E1 (Boston Biochem), 100 nM relevant E2-conjugating enzyme (UbcH5a [Boston Biochem]), $10 mM radiolabeled 125 I-ubiquitin (stabilized with 0.25% bovine serum albumin, Amersham), 0.2-1.6 mM purified recombinant chicken FANCL, and substrates at various concentrations (as indicated in detail in the figure legends) in reaction buffer (50 mM Tris [pH 7.4], 2.5 mM MgCl 2 , 150 mM NaCl, 0.1 mM DTT, 0.01% Triton X-100, 10% glycerol, and 2 mM ATP [Boston Biochem]). Reactions were incubated for 60 min at 37 C, stopped by adding SDS sample buffer supplemented with 5 mM 2-mercaptoethanol, and boiled for 5 min. Reaction products were resolved on 4%-12% Bis-Tris-PAGE (Invitrogen) gel, and 125 I-labeled products were visualized by Phosphoimager (Molecular Dynamic Typhoon) and quantified using ImageJ software. Where indicated, unlabeled ubiquitin (SIGMA) or methylubiquitin (Boston Biochem) was added in various amounts (60 nM-6 mM) to the reactions.
Bioinformatic Analysis of FANCL
The human FANCL protein sequence (GenBank ID 116241360, 375 amino acids) was used as a starting point to identify homologous proteins from the ''nr'' database using PSI-Blast (PMID: 9254694) . This allowed identification of the FANCL orthologs from several genomes, including the recently sequenced basal eukaryotic genomes such as the unicellular choanoflagellate (the closest known relatives of metazoans) Monosiga brevicollis (GenBank ID 163778323), the parabasilid Trichomonas vaginalis (GenBank ID 123455915), the placazoa Trichoplax adhaerens (GenBank ID 196011804) , the moss Physcomitrella patens (GenBank ID 168040860), and the green alga Chlamydomonas reinhardtii (GenBank ID 159482773). The M. brevicollis protein is predicted to be around 2041 amino acids, which is unusually large for a FANCL ortholog. This protein, however, shows very high similarity to the human FANCL only in the last 230 amino acids in the C-terminal region. Therefore, this protein is likely to be a gene prediction error or a gene fusion of two proximally located genes. In addition, we also identified the orthologs of FANCL from Dictyostelium discoideum (GenBank ID 66801111), several plants (e.g., Arabidopsis thaliana, GenBank ID 79332463; Zea mays, GenBank ID 194691460), nonbilateran metazoan genome (the cnidaria Nematostella vectensis, GenBank ID 156375663), and several bilateran genomes (e.g., the echinoderm Strongylocentrotus purpuratus, GenBank ID 72007233; Drosophila melanogaster, GenBank ID 24645585; Danio rerio, GenBank ID 55742057; Xenopus laevis, GenBank ID 147900806; Gallus gallus, GenBank ID 76780853; Mus musculus, GenBank ID 13385416). The widespread presence of FANCL in organisms from several different branches of the eukaryotic lineage suggests that the FANCL protein was present in the last common ancestor of all eukaryotes.
A systematic analysis of the human FANCL sequence revealed the presence of a RING finger domain from position 299 to 370, with the conserved metalchelating residues (Meetei et al., 2003) . We then analyzed the rest of the sequence to identify the presence of any additional domains. A PSI-Blast search with the region 100 to 220 from the human FANCL picked up a ubiquitin-conjugating enzyme E2 from the diplomonad Giardia lamblia (GenBank ID 159117075), albeit with a low BLAST e-value of 1e-02 in the fifth iteration. This prompted us to perform a fold recognition search using 3D-PSSM (PMID: 10860755) which combines multiple sequence profiles with knowledge of protein structure. In short, 3D-PSSM uses structural alignments of homologous proteins of similar three-dimensional structure in the structural classification of proteins (SCOP) database (PMID: 7723011) to obtain a structural equivalence of residues. These equivalences are used to extend multiply aligned sequences obtained by standard sequence searches. The resulting multiple sequence alignment is then converted into a PSSM. This is finally combined with secondary structure matching and solvation potentials to recognize structural relationships in the fold library. 3D-PSSM predicts this region (with 80% accuracy and a PSSM e-value of 1.27e-01) to adopt an UBC-like fold with the best hit to the structure PDB: 2E2C (E2-C protein; a ubiquitin-conjugating enzyme). A search using Phyre (PMID: 17876813) picked up GCN2 (PDB: 2ebm) as its best hit. The match is to an RWD domain, which adopts the same fold as the UBCs (i.e., UBC-like fold) but is catalytically inactive (PMIDs: 18276160 and 11779830). A careful analysis of the sequence alignment and the conserved residues revealed the conservation of an important PxxxP motif (PMIDs: 15273307, 18276160, and 17956732), which has been shown to adopt a triple-turn motif in the RWD domain and to be critical for maintaining the fold. A multiple sequence alignment of this region was prepared using MUSCLE and was used to perform a secondary structure prediction using the Jpred-3 server (PMID: 18463136). This revealed the congruence in the predicted secondary structure and that of the UBC fold. Taken together, these observations consistently suggest that this region is therefore not likely to adopt a WD40-like beta-propeller structure as previously thought. Instead, we predict that this region is more likely to adopt an RWD/UBC-like fold.
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